|beta2 adrenergic receptor siRNA
|siRNA instillation, IOP measurements
|siRNA designed for beta2 adrenergic receptor induced a reduction of intraocular pressure of 30±5%, compared to a control. The results in terms of IOP decrease were similar to that found with commercial compounds but a long-lasting hypotensive action was shown by beta2 adrenergic receptor siRNA treatment as compared to commercial drugs.
|Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits.
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.